Drake & Associates’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,763
Closed -$928K 108
2025
Q4
$928K Buy
4,763
+365
+8% +$86.9K 0.18% 59
2025
Q3
$1.1M Sell
4,398
-212
-5% -$54K 0.23% 53
2025
Q2
$1.01M Sell
4,610
-1,336
-22% -$216K 0.25% 47
2025
Q1
$831K Buy
5,946
+853
+17% +$139K 0.23% 45
2024
Q4
$889K Sell
5,093
-178
-3% -$31.6K 0.25% 44
2024
Q3
$898K Buy
5,271
+942
+22% +$136K 0.29% 28
2024
Q2
$611K Sell
4,329
-317
-7% -$39.4K 0.22% 31
2024
Q1
$584K Buy
4,646
+42
+0.9% +$4.81K 0.21% 33
2023
Q4
$485K Buy
4,604
+1,661
+56% +$181K 0.2% 38
2023
Q3
$312K Sell
2,943
-61
-2% -$7.06K 0.14% 54
2023
Q2
$358K Buy
+3,004
New +$311K 0.16% 50

Other funds holding ORCL

Drake & Associates's ORCL Position: Q1 2026 in Review

Drake & Associates sold out of Oracle (ORCL) in Q1 2026, closing a stake of 4,763 shares — an estimated $928K sold.

Drake & Associates first reported a position in ORCL in Q2 2023 and held it in 11 quarters. The position peaked at $1.1M in Q3 2025. 3,494 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Drake & Associates reported no remaining Oracle position as of Q1 2026 after selling out during the quarter.
  • Drake & Associates sold 4,763 Oracle shares in Q1 2026, an estimated $928K.
  • Drake & Associates first reported a position in Oracle in Q2 2023 and held it in 11 quarters.
  • Drake & Associates's Oracle position peaked at $1.1M in Q3 2025.
  • 3,494 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Drake & Associates's 13F filing for Q1 2026, filed 13 May 2026.